Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juluca PK in ESRD Patients on Hemodialysis
NCT04431518Phase 4Completed
- Sponsor
- Indiana University
- Start
- Apr 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir + rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Indiana University. Started Apr 2021; status: completed.
02
Drugs
dolutegravir + rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04431518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431518.